AZN logo

AstraZeneca (AZN) Working capital

annual working capital:

-$2.04B+$3.45B(+62.85%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AZN annual working capital is -$2.04 billion, with the most recent change of +$3.45 billion (+62.85%) on December 31, 2024.
  • During the last 3 years, AZN annual working capital has fallen by -$5.69 billion (-155.86%).
  • AZN annual working capital is now -124.44% below its all-time high of $8.34 billion, reached on December 31, 2010.

Performance

AZN Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

quarterly working capital:

-$2.99B(NaN%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN quarterly working capital is -$2.99 billion
  • Over the past year, AZN quarterly working capital has increased by +$317.00 million (+9.59%).
  • AZN quarterly working capital is now -133.77% below its all-time high of $8.85 billion, reached on June 30, 2011.

Performance

AZN quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

AZN Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+62.9%+9.6%
3 y3 years-155.9%-3115.1%
5 y5 years+20.2%+29.2%

AZN Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-155.9%+62.9%-3115.1%+50.9%
5 y5-year-155.9%+62.9%-159.2%+50.9%
alltimeall time-124.4%+62.9%-133.8%+66.2%

AZN Working capital History

DateAnnualQuarterly
Mar 2025
-
-$2.99B(+68.8%)
Dec 2024
-$2.04B(-62.8%)
-
Sep 2024
-
-$1.77B(-44.2%)
Jun 2024
-
-$3.17B(-4.1%)
Mar 2024
-
-$3.31B(-45.7%)
Dec 2023
-$5.49B(+48.3%)
-
Sep 2023
-
-$6.09B(+72.1%)
Jun 2023
-
-$3.54B(+36.3%)
Mar 2023
-
-$2.59B(-29.9%)
Dec 2022
-$3.70B(-201.4%)
-$3.70B(-20.0%)
Sep 2022
-
-$4.63B(+415.1%)
Jun 2022
-
-$898.00M(+865.6%)
Mar 2022
-
-$93.00M(-102.5%)
Dec 2021
$3.65B(-578.4%)
$3.65B(+20.0%)
Sep 2021
-
$3.04B(-39.8%)
Jun 2021
-
$5.05B(-281.9%)
Mar 2021
-
-$2.78B(+264.1%)
Dec 2020
-$763.00M(-70.1%)
-$763.00M(-1.7%)
Sep 2020
-
-$776.00M(-76.1%)
Jun 2020
-
-$3.25B(-22.9%)
Mar 2020
-
-$4.22B(+65.3%)
Dec 2019
-$2.55B(+264.3%)
-$2.55B(+103.3%)
Sep 2019
-
-$1.26B(+54.1%)
Jun 2019
-
-$815.00M(-82.3%)
Mar 2019
-
-$4.61B(+557.2%)
Dec 2018
-$701.00M(-78.3%)
-$701.00M(-67.2%)
Sep 2018
-
-$2.14B(-55.0%)
Jun 2018
-
-$4.75B(-4.6%)
Mar 2018
-
-$4.98B(+54.1%)
Dec 2017
-$3.23B(+62.1%)
-$3.23B(+290.0%)
Sep 2017
-
-$829.00M(-39.0%)
Jun 2017
-
-$1.36B(-64.2%)
Mar 2017
-
-$3.79B(+90.2%)
Dec 2016
-$1.99B(-275.2%)
-$1.99B(-20.7%)
Sep 2016
-
-$2.52B(+147.9%)
Jun 2016
-
-$1.01B(-67.9%)
Mar 2016
-
-$3.16B(-377.9%)
Dec 2015
$1.14B(-279.8%)
$1.14B(-140.1%)
Sep 2015
-
-$2.84B(+21.3%)
Jun 2015
-
-$2.34B(-23.8%)
Mar 2015
-
-$3.07B(+384.5%)
Dec 2014
-$633.00M(-114.8%)
-$633.00M(-15.8%)
Sep 2014
-
-$752.00M(+537.3%)
Jun 2014
-
-$118.00M(-87.8%)
Mar 2014
-
-$971.00M(-122.7%)
Dec 2013
$4.28B(-16.7%)
$4.28B(+4.1%)
Sep 2013
-
$4.12B(-1.9%)
Jun 2013
-
$4.20B(-6.4%)
Mar 2013
-
$4.48B(-12.9%)
Dec 2012
$5.14B(-33.6%)
$5.14B(+31.9%)
Sep 2012
-
$3.90B(-21.6%)
Jun 2012
-
$4.98B(-13.6%)
Mar 2012
-
$5.76B(-25.7%)
Dec 2011
$7.75B(-7.1%)
$7.75B(-0.7%)
Sep 2011
-
$7.81B(-11.8%)
Jun 2011
-
$8.85B(+18.8%)
Mar 2011
-
$7.45B(-10.7%)
DateAnnualQuarterly
Dec 2010
$8.34B(+36.3%)
$8.34B(+8.1%)
Sep 2010
-
$7.72B(+9.1%)
Jun 2010
-
$7.07B(+32.1%)
Mar 2010
-
$5.35B(-12.5%)
Dec 2009
$6.12B(+149.4%)
$6.12B(+12.8%)
Sep 2009
-
$5.42B(+36.2%)
Jun 2009
-
$3.98B(+120.9%)
Mar 2009
-
$1.80B(-26.5%)
Dec 2008
$2.45B(+29.5%)
$2.45B(+120.3%)
Sep 2008
-
$1.11B(+129.7%)
Jun 2008
-
$485.00M(-139.4%)
Mar 2008
-
-$1.23B(-164.9%)
Dec 2007
$1.90B(-74.7%)
$1.90B(-326.4%)
Sep 2007
-
-$837.00M(-90.5%)
Jun 2007
-
-$8.86B(-249.1%)
Mar 2007
-
$5.94B(-20.7%)
Dec 2006
$7.49B(+8.1%)
$7.49B(+18.0%)
Sep 2006
-
$6.34B(-4.5%)
Jun 2006
-
$6.65B(-11.3%)
Mar 2006
-
$7.49B(+8.1%)
Dec 2005
$6.93B(+7.7%)
$6.93B(+9.1%)
Sep 2005
-
$6.35B(-4.3%)
Jun 2005
-
$6.64B(-4.2%)
Mar 2005
-
$6.93B(+7.7%)
Dec 2004
$6.44B(+22.9%)
$6.44B(+17.2%)
Sep 2004
-
$5.49B(+10.9%)
Jun 2004
-
$4.95B(-10.2%)
Mar 2004
-
$5.51B(+5.3%)
Dec 2003
$5.24B(+33.9%)
$5.24B(-11.2%)
Sep 2003
-
$5.90B(+14.7%)
Jun 2003
-
$5.14B(+7.4%)
Mar 2003
-
$4.79B(+22.5%)
Dec 2002
$3.91B(+0.7%)
$3.91B(-15.5%)
Sep 2002
-
$4.63B(+8.8%)
Jun 2002
-
$4.26B(-6.3%)
Mar 2002
-
$4.54B(+16.9%)
Dec 2001
$3.88B(+7.3%)
$3.88B(-18.3%)
Sep 2001
-
$4.76B(+6.1%)
Jun 2001
-
$4.48B(+0.1%)
Mar 2001
-
$4.48B(+23.6%)
Dec 2000
$3.62B(+25.1%)
$3.62B(-7.7%)
Sep 2000
-
$3.92B(+13.6%)
Jun 2000
-
$3.45B(-4.4%)
Mar 2000
-
$3.61B(+24.8%)
Dec 1999
$2.90B(-22.9%)
$2.90B(-31.2%)
Sep 1999
-
$4.21B(+10.6%)
Jun 1999
-
$3.81B(+1.4%)
Dec 1998
$3.75B(+128.7%)
$3.75B(+152.6%)
Jun 1998
-
$1.49B(-9.5%)
Dec 1997
$1.64B(-17.7%)
$1.64B(-17.7%)
Dec 1996
$2.00B(+14.9%)
$2.00B(+14.9%)
Dec 1995
$1.74B(+9.7%)
$1.74B(-1.2%)
Jun 1995
-
$1.76B(+10.9%)
Dec 1994
$1.58B(+12.8%)
$1.58B(+12.8%)
Dec 1993
$1.40B(-817.5%)
$1.40B
Dec 1992
-$195.65M(-109.6%)
-
Dec 1991
$2.04B(+5.6%)
-
Dec 1990
$1.93B
-

FAQ

  • What is AstraZeneca annual working capital?
  • What is the all time high annual working capital for AstraZeneca?
  • What is AstraZeneca annual working capital year-on-year change?
  • What is AstraZeneca quarterly working capital?
  • What is the all time high quarterly working capital for AstraZeneca?
  • What is AstraZeneca quarterly working capital year-on-year change?

What is AstraZeneca annual working capital?

The current annual working capital of AZN is -$2.04B

What is the all time high annual working capital for AstraZeneca?

AstraZeneca all-time high annual working capital is $8.34B

What is AstraZeneca annual working capital year-on-year change?

Over the past year, AZN annual working capital has changed by +$3.45B (+62.85%)

What is AstraZeneca quarterly working capital?

The current quarterly working capital of AZN is -$2.99B

What is the all time high quarterly working capital for AstraZeneca?

AstraZeneca all-time high quarterly working capital is $8.85B

What is AstraZeneca quarterly working capital year-on-year change?

Over the past year, AZN quarterly working capital has changed by +$317.00M (+9.59%)
On this page